Terms: = Skin cancer AND BRCA1, BRCAI, 672, ENSG00000012048, IRIS, BRCC1, RNF53, PSCP
1015 results:
1. Influence of Post-radiation Ocular Surface Disorder on Ocular Surgery: A Case Report and Review of the Literature.
Gjukaj D; Morina I; Valmaggia C; Ammann D; Todorova MG
Klin Monbl Augenheilkd; 2024 Apr; 241(4):421-425. PubMed ID: 38653304
[TBL] [Abstract] [Full Text] [Related]
2. The comparison of effectivity in breast cancer prevention between skin sparing and subcutaneous mastectomy - 20 years of experience.
Berkeš A; Streit L; Dražan L; Veselý J; Bajus A; Kubek T; Šedivý O; Kanuščák K; Feiková K; Strmiska O; Bohušová M
Acta Chir Plast; 2023; 65(3-4):112-116. PubMed ID: 38538298
[TBL] [Abstract] [Full Text] [Related]
3. Clinicopathological study of ophthalmic cutaneous and mucocutaneous non-langerhans cell histiocytic lesions.
Alkatan HM; Fatani DR; Maktabi AMY; Alzahem TA
BMC Ophthalmol; 2024 Mar; 24(1):124. PubMed ID: 38504269
[TBL] [Abstract] [Full Text] [Related]
4. An optimized 3T MRI scan protocol to assess iris melanoma with subsequent histopathological verification - A prospective study.
Lim JZ; Gokul A; Misra SL; Pan X; Charlton A; McGhee CNJ
Asia Pac J Ophthalmol (Phila); 2024; 13(2):100047. PubMed ID: 38417788
[TBL] [Abstract] [Full Text] [Related]
5. Emerging therapeutic strategies for metastatic uveal melanoma: Targeting driver mutations.
Liu XL; Run-Hua Z; Pan JX; Li ZJ; Yu L; Li YL
Pigment Cell Melanoma Res; 2024 May; 37(3):411-425. PubMed ID: 38411373
[TBL] [Abstract] [Full Text] [Related]
6. Impact of iris color on uveal melanoma-related outcomes in 7245 patients at a single ocular oncology center.
Zaloga AR; DeYoung C; Kurian DE; Card KR; Caudill GB; Zeiger JS; Shields CL
Asia Pac J Ophthalmol (Phila); 2024; 13(1):100031. PubMed ID: 38383076
[TBL] [Abstract] [Full Text] [Related]
7. Correlation of fitzpatrick skin type and iris color with tumor size in 823 patients with uveal melanoma.
Agrawal KU; Barke MR; Chiang L; Ni R; Kim RS; Zhang Q; Shields CL
Asia Pac J Ophthalmol (Phila); 2024; 13(2):100046. PubMed ID: 38320655
[TBL] [Abstract] [Full Text] [Related]
8. Management of Uveal Melanoma: Updated cancer Care Alberta Clinical Practice Guideline.
Weis E; Surgeoner B; Salopek TG; Cheng T; Hyrcza M; Kostaras X; Larocque M; McKinnon G; McWhae J; Menon G; Monzon J; Murtha AD; Walker J; Temple-Oberle C
Curr Oncol; 2023 Dec; 31(1):24-41. PubMed ID: 38275828
[TBL] [Abstract] [Full Text] [Related]
9. Genetic Risk Factors for Early-Onset Merkel Cell Carcinoma.
Mohsin N; Hunt D; Yan J; Jabbour AJ; Nghiem P; Choi J; Zhang Y; Freeman AF; Bergerson JRE; Dell'Orso S; Lachance K; Kulikauskas R; Collado L; Cao W; Lack J; Similuk M; Seifert BA; Ghosh R; Walkiewicz MA; Brownell I
JAMA Dermatol; 2024 Feb; 160(2):172-178. PubMed ID: 38170500
[TBL] [Abstract] [Full Text] [Related]
10. iris Neovascularization After Vitreous Metastasis of a Cutaneous Melanoma.
Leone G; Nassisi M; Viola F
JAMA Ophthalmol; 2023 Dec; 141(12):e233540. PubMed ID: 38127080
[TBL] [Abstract] [Full Text] [Related]
11. MC1R and age heteroclassification of face phenotypes in the Rio Grande do Sul population.
Bettim CA; da Silva AV; Kahmann A; Dorn M; Alho CS; Avila E
Int J Legal Med; 2024 May; 138(3):859-872. PubMed ID: 38087053
[TBL] [Abstract] [Full Text] [Related]
12. Comprehensive causes of death in uveal melanoma: mortality in 1530 consecutively diagnosed patients followed until death.
Stålhammar G
JNCI Cancer Spectr; 2023 Oct; 7(6):. PubMed ID: 37972025
[TBL] [Abstract] [Full Text] [Related]
13. Functional assay for assessment of pathogenicity of BAP1 variants.
Repo PE; Backlund MP; Kivelä TT; Turunen JA
Hum Mol Genet; 2024 Feb; 33(5):426-434. PubMed ID: 37956408
[TBL] [Abstract] [Full Text] [Related]
14. Pediatric ocular melanoma: a collaborative multicenter study and meta-analysis.
Masoomian B; Dalvin LA; Riazi-Esfahani H; Ghassemi F; Azizkhani M; Mirghorbani M; Khorrami-Nejad M; Sajjadi Z; Kaliki S; Sagoo MS; Al Harby L; Al-Jamal RT; Kivelä TT; Giblin M; Lim LS; Shields CL
J AAPOS; 2023 Dec; 27(6):316-324. PubMed ID: 37949393
[TBL] [Abstract] [Full Text] [Related]
15. Multifocal choroidal melanoma: a clinicohistopathological correlation.
Ketkar M; Jakati S; Raval V
BMJ Case Rep; 2023 Nov; 16(11):. PubMed ID: 37914164
[TBL] [Abstract] [Full Text] [Related]
16. Worldwide Incidence of Ocular Melanoma and Correlation With Pigmentation-Related Risk Factors.
Wu M; Yavuzyigitoglu S; Brosens E; Ramdas WD; Kiliç E;
Invest Ophthalmol Vis Sci; 2023 Oct; 64(13):45. PubMed ID: 37902747
[TBL] [Abstract] [Full Text] [Related]
17. Tumor Profiles of Late Presentation Uveal Ring Melanoma With Novel Characteristics - A Case Series.
Lim JZ; Crawford AZ; McGhee CNJ
Invest Ophthalmol Vis Sci; 2023 Oct; 64(13):44. PubMed ID: 37889509
[TBL] [Abstract] [Full Text] [Related]
18. iris melanoma: Review of clinical features, risks, management, and outcomes.
Cherkas E; Kalafatis NE; Marous MR; Shields CL
Clin Dermatol; 2024; 42(1):62-70. PubMed ID: 37865279
[TBL] [Abstract] [Full Text] [Related]
19. Whole exome germline sequencing in early-onset prostate cancer patients: Genomic findings and clinical outcomes.
Siegelmann-Danieli N; Neiman V; Bareket-Samish A; Berger R; Peretz A; Alapi H; Tsur E; Patalon T; Beller D; Rimler G; Chodick G; Shohat M
Prostate; 2024 Jan; 84(1):39-46. PubMed ID: 37842866
[TBL] [Abstract] [Full Text] [Related]
20. Comparison of three-weekly and six-weekly pembrolizumab United Kingdom prescribing practice for advanced and resected melanoma.
Mehta I; Dayimu A; Kumar S; Boobier C; Oladipo O; Burke D; Olson-Brown A; Yesildag P; Nobes J; Brown S; Booth C; Wheater M; Muller D; Fountain V; Ford L; Board R; McGurk L; Twelves S; Demiris N; Corrie P
Eur J Cancer; 2023 Nov; 194():113344. PubMed ID: 37804771
[TBL] [Abstract] [Full Text] [Related]
[Next]
